354 related articles for article (PubMed ID: 29324443)
1. Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
Chockley PJ; Chen J; Chen G; Beer DG; Standiford TJ; Keshamouni VG
J Clin Invest; 2018 Apr; 128(4):1384-1396. PubMed ID: 29324443
[TBL] [Abstract][Full Text] [Related]
2. High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer.
Li H; Wang C; Lan L; Behrens A; Tomaschko M; Ruiz J; Su Q; Zhao G; Yuan C; Xiao X; Li B; Yan L; Wu W; Li W; Chen J; He Y; Zhang C
Aging (Albany NY); 2021 Feb; 13(4):5197-5225. PubMed ID: 33535187
[TBL] [Abstract][Full Text] [Related]
3. Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
Goswami MT; Reka AK; Kurapati H; Kaza V; Chen J; Standiford TJ; Keshamouni VG
Oncogene; 2016 Apr; 35(15):1888-98. PubMed ID: 26148233
[TBL] [Abstract][Full Text] [Related]
4. Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.
MacFawn I; Wilson H; Selth LA; Leighton I; Serebriiskii I; Bleackley RC; Elzamzamy O; Farris J; Pifer PM; Richer J; Frisch SM
Mol Immunol; 2019 Jan; 105():137-149. PubMed ID: 30508726
[TBL] [Abstract][Full Text] [Related]
5. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis H37Rv infected THP-1 cells induce epithelial mesenchymal transition (EMT) in lung adenocarcinoma epithelial cell line (A549).
Gupta PK; Tripathi D; Kulkarni S; Rajan MG
Cell Immunol; 2016 Feb; 300():33-40. PubMed ID: 26677761
[TBL] [Abstract][Full Text] [Related]
7. Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer.
Salazar Y; Zheng X; Brunn D; Raifer H; Picard F; Zhang Y; Winter H; Guenther S; Weigert A; Weigmann B; Dumoutier L; Renauld JC; Waisman A; Schmall A; Tufman A; Fink L; Brüne B; Bopp T; Grimminger F; Seeger W; Pullamsetti SS; Huber M; Savai R
J Clin Invest; 2020 Jul; 130(7):3560-3575. PubMed ID: 32229721
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.
Ricciardi M; Zanotto M; Malpeli G; Bassi G; Perbellini O; Chilosi M; Bifari F; Krampera M
Br J Cancer; 2015 Mar; 112(6):1067-75. PubMed ID: 25668006
[TBL] [Abstract][Full Text] [Related]
9. NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
Cantoni C; Huergo-Zapico L; Parodi M; Pedrazzi M; Mingari MC; Moretta A; Sparatore B; Gonzalez S; Olive D; Bottino C; Castriconi R; Vitale M
J Immunol Res; 2016; 2016():4684268. PubMed ID: 27294158
[TBL] [Abstract][Full Text] [Related]
10. FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells.
Shen M; Tsai Y; Zhu R; Keng PC; Chen Y; Chen Y; Lee SO
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):313-322. PubMed ID: 29306075
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation.
Wang A; Lu C; Ning Z; Gao W; Xie Y; Zhang N; Liang J; Abbasi FS; Yan Q; Liu J
Oncotarget; 2017 Apr; 8(17):28247-28259. PubMed ID: 28423676
[TBL] [Abstract][Full Text] [Related]
12. Control of Metastasis by NK Cells.
López-Soto A; Gonzalez S; Smyth MJ; Galluzzi L
Cancer Cell; 2017 Aug; 32(2):135-154. PubMed ID: 28810142
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal transition hinders interferon-γ-dependent immunosurveillance in lung cancer cells.
Tseng PC; Chen CL; Lee KY; Feng PH; Wang YC; Satria RD; Lin CF
Cancer Lett; 2022 Jul; 539():215712. PubMed ID: 35490920
[TBL] [Abstract][Full Text] [Related]
14. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
Dopeso H; Jiao HK; Cuesta AM; Henze AT; Jurida L; Kracht M; Acker-Palmer A; Garvalov BK; Acker T
Cancer Res; 2018 Apr; 78(7):1805-1819. PubMed ID: 29339541
[TBL] [Abstract][Full Text] [Related]
15. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.
Zaynagetdinov R; Sherrill TP; Gleaves LA; McLoed AG; Saxon JA; Habermann AC; Connelly L; Dulek D; Peebles RS; Fingleton B; Yull FE; Stathopoulos GT; Blackwell TS
Cancer Res; 2015 Apr; 75(8):1624-1634. PubMed ID: 25691457
[TBL] [Abstract][Full Text] [Related]
17. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
Castañón E; Soltermann A; López I; Román M; Ecay M; Collantes M; Redrado M; Baraibar I; López-Picazo JM; Rolfo C; Vidal-Vanaclocha F; Raez L; Weder W; Calvo A; Gil-Bazo I
Cancer Lett; 2017 Aug; 402():43-51. PubMed ID: 28549790
[TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
19. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
Sun W; Feng J; Yi Q; Xu X; Chen Y; Tang L
Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
[TBL] [Abstract][Full Text] [Related]
20. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
